Team:Trieste/parts/9
From 2012.igem.org
Corsogiulia (Talk | contribs) |
Samarisara (Talk | contribs) |
||
Line 60: | Line 60: | ||
<li><a href="https://2012.igem.org/Team:Trieste/parts/7">BBa_K875007 - PelB SIP </a></li> | <li><a href="https://2012.igem.org/Team:Trieste/parts/7">BBa_K875007 - PelB SIP </a></li> | ||
<li><a href="https://2012.igem.org/Team:Trieste/parts/8">BBa_K875008 - Tse2 Toxin</a></li> | <li><a href="https://2012.igem.org/Team:Trieste/parts/8">BBa_K875008 - Tse2 Toxin</a></li> | ||
- | <li><a href="https://2012.igem.org/Team:Trieste/parts/9">BBa_K875009 - LL 37</a></li> | + | <li class="select"><a href="https://2012.igem.org/Team:Trieste/parts/9">BBa_K875009 - LL 37</a></li> |
<li><a href="https://2012.igem.org/Team:Trieste/parts/10">BBa_K875020 - Glucosidase</a></li> | <li><a href="https://2012.igem.org/Team:Trieste/parts/10">BBa_K875020 - Glucosidase</a></li> | ||
</strong> | </strong> |
Revision as of 08:44, 26 September 2012
BBa_K875009
More
Description
LL-37 is a 37-residue, amphipathic, helical peptide found throughout the body and has been shown to exhibit a broad spectrum of antimicrobial activity.
Assembly
Obtained by synthesis
Looking forward
At the beginning, our idea was to use the LL 37 cathelicidin as a toxin, to kill the bacteria from inside. Unfortunately this approach was unsuccessfully as the LL 37 does not kill the bacteria. We thought to use the LL 37 in another way, combined with the T4 holin, (BBa_K112000) a small bacteriophage-encoded proteins that accumulate during the period of late-protein synthesis after infection and cause lysis of the host cell at a precise genetically programmed time. The rational of this construct is to create a synergic action were the holin creates the pores through which the LL 37 can reach his target.